InterVenn is a life science company unlocking the value of glycoproteomics—glycosylated proteins which are responsible for driving protein function—for the development of transformational healthcare solutions. The glycoproteome is a source of life-critical information about human biology that has the potential to improve patient outcomessignificantly. Still, it has remained inaccessible due to its vast complexity. InterVenn has pioneered a first-of-its-kind AI-powered platform to decode this layer of biology at a clinically meaningful scale for the first time in history. The company’s platform can produce a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and, potentially, therapeutics. Its proprietary technology platform is accessible to pharma partners seeking rich biology insights to propel their research and development efforts. Founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert & serial entrepreneur Aldo Carrascoso, InterVenn will contribute to making the new era of personalized, predictive, and preventative care a reality. For more information about InterVenn, visit www.intervenn.com.

AI/ML

Biotechnology

Health Care

InterVenn Biosciences

Norton Kitagawa

Roselio Viray

Charmie Raterta , CPA

Daniel Serie

James Richard Hartness Jr

Kaitlynn Moser

Xin Cong

Rudy Peters

Jessie Siat

Maichel Empredo

Anjo Zulaybar

Ruth Tria, CPA

Tal K.

Harold Viduya

Jojo Santos

Katelyne Arda

Kristal Kamatoy

Alex Vanotti

The Leadership Team at InterVenn Biosciences is responsible for setting the strategic direction and operational execution of the company's innovative initiatives in glycoproteomics. Comprising experts in medical affairs, technology operations, and bioinformatics, this team drives the development of groundbreaking clinical applications and partnerships, ensuring the alignment of research efforts with the company's mission to revolutionize healthcare solutions through advanced AI and deep biological insights. Their collaborative leadership fosters an environment of innovation and excellence, enabling InterVenn to advance personalized medicine and improve patient outcomes.

Leadership Team

Clinical Research and Data Analysis

Business Operations and Support

Engineering and Development

Leadership Team

About

Team members

Other teams at InterVenn Biosciences

Clinical Research and Data Analysis

Business Operations and Support

Engineering and Development